Rubicon Research per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
₹17.74₹15.52
₹17.56₹15.31
₹78.07₹78.07
₹117.26₹106.24
—₹12.42
−₹1.46−₹1.46
—₹0.02
16.516.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RUBICON₹1,559.30

Rubicon Research Ltd.

· Pharma & Health
₹ CrorePeersSHILPAMEDSPARCSTARSUPRIYAPARKHOSPSTHYROCAREMETROPOLISMARKSANSMcap ₹25,742 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS15.5217.74
Diluted EPS15.3117.56
Book Value per Share78.0778.07
Revenue per Share106.24117.26
Cash Flow per Share12.42—
Free Cash Flow per Share-1.46-1.46
Dividends per Share0.02—
Shares Outstanding (cr)16.516.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.